< Back to previous page
Researcher
Bram Verstockt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2015 → Today
Projects
1 - 5 of 5
- Gastroenterology > Inflammatory Bowel disease > personalised medicine; biomarkers; multi-omicsFrom1 Jun 2022 → TodayFunding: BOF - various
- Role of eosinophils in gut inflammation and fibrosis in inflammatory bowel diseasesFrom5 Mar 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- “Predicting response to therapy in inflammatory bowel diseases ”From23 Sep 2019 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Predicting response to treatment in patients with inflammatory bowel diseaseFrom1 Jan 2017 → TodayFunding: Foreign private sponsor - undefined
- Predicting outcomes of inflammatory bowel diseases: creating opportunities for personalized medicineFrom1 Oct 2015 → 30 Sep 2019Funding: FWO fellowships
Publications
1 - 10 of 135
- Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways.(2022)
Authors: Bram Verstockt
Pages: 15 - A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis.(2022)
Authors: Padhmanand Sudhakar, Bram Verstockt, Séverine Vermeire
Pages: 2299 - Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era(2022)
Authors: Dahham Alsoud, Bram Verstockt
Pages: 885 - 886Number of pages: 2 - Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?(2022)
Authors: Bram Verstockt
Pages: 1370 - 1382 - How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?(2022)
Authors: Bram Verstockt
Pages: 1383 - 1395 - Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.(2022)
Authors: Bram Verstockt
Pages: 500 - 505 - ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment(2022)
Authors: Bram Verstockt
Pages: 2 - 17Number of pages: 16 - Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises.(2022)
Authors: Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Pages: 100089 - Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: single-center randomized controlled trial(2021)
Authors: I-Hsuan Huang, Pieter Sinonquel, Wout Verbeure, Bram Verstockt, Raf Bisschops, Jan Tack
Pages: 81 - 83Number of pages: 3 - Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?(2021)
Authors: Inge Jacobs, Matthias Ceulemans, Lucas Wauters, Christine Breynaert, Séverine Vermeire, Bram Verstockt, Tim Vanuytsel
Number of pages: 17